Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  sipuleucel-T
Find trials that include:  Any drugs shown
Results 1-8 of 8 for your search:
Start Over
Sipuleucel-T with or without Indoximod in Treating Patients with Metastatic Hormone-Resistant Prostate Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2011LS109, NCI-2012-00923, NCT01560923
Sipuleucel-T with or without DNA Vaccine Therapy in Treating Patients with Hormone-Resistant Metastatic Prostate Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CO11816, NCI-2012-02026, NCT01706458
Sipuleucel-T and Stereotactic Ablative Body Radiation Therapy in Treating Patients with Metastatic Hormone-Resistant Prostate Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: STU 102012-026, NCI-2015-01669, NCT01818986
Immediate or Delayed Ipilimumab after Sipuleucel-T Treatment in Treating Patients with Metastatic Hormone-Resistant Prostate Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12557, NCI-2014-00318, 079730, CC#12557, NCT01804465
Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: 18 and over
Trial IDs: P11-4, NCI-2015-00139, NCT01727154
Radiation Therapy in Treating Patients with Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 223912, NCI-2013-00633, NCT01833208
Immune Activation in Patients with Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T Immunotherapy
Status: Active
Phase: No phase specified
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: Pro00047231, NCI-2015-02074, NCT02036918
Start Over